Huitt Tracey
Patrimonio netto: 21 600 $ in data 30/06/2026
Patrimonio netto: 21 600 $ in data 30/06/2026
Currently, Huitt Tracey is an Independent Director at Iconic Minerals Ltd. since 2014 and Head-Investor Relations at NervGen Pharma Corp.
Formerly, Mr. Tracey was an Independent Director at C21 Investments, Inc. from 2013 to 2015, a Director at Quantum Solar Power Corp.
in 2010, and an Independent Director at Anquiro Ventures Ltd.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/02/2026 | 200.000 ( 4,44% ) | 17 400 $ | 31/01/2020 | |
ICONIC MINERALS LTD 0,05% | 02/04/2026 | 100.000 ( 0,05% ) | 4 200 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ICONIC MINERALS LTD. | Direttore/Membro del Consiglio | 23/07/2014 |
| NERVGEN PHARMA CORP. | Contatto Relazioni con gli Investitori | - |
| Società | Posizione | Fine |
|---|---|---|
| C21 INVESTMENTS INC. | Direttore/Membro del Consiglio | 18/06/2015 |
| QUANTUM SOLAR PWR | Direttore/Membro del Consiglio | 16/07/2010 |
| ANQUIRO VENTURES LTD. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Iconic Minerals Ltd.
Iconic Minerals Ltd. Chemicals: AgriculturalProcess Industries Explores lithium projects | Process Industries |
C21 Investments, Inc.
C21 Investments, Inc. Agricultural Commodities/MillingProcess Industries Engages in cultivation, processing and distribution of cannabis | Process Industries |
Quantum Solar Power Corp.
Quantum Solar Power Corp. Electric UtilitiesUtilities Develops and commercializes solar power technology | Utilities |
Anquiro Ventures Ltd.
Anquiro Ventures Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale